Exicure Inc (XCUR) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 8-K/A - Current report: [Amend]

CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

Please replace the release dated January 22, 2025 with the following corrected version due to multiple revisions. The updated release reads:...

Form 8-K - Current report

Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

Exicure, Inc. (Nasdaq: XCUR, “the Company”, “Exicure”), today announced that on January 19, 2025, Exicure Inc. (“the Company”) entered into a...

Form 8-K - Current report

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics...

Form 8-K - Current report

Form 8-K/A - Current report: [Amend]

Form 3 - Initial statement of beneficial ownership of securities

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

Please replace the release dated December 20, 2024 with the following corrected version due to multiple revisions. The updated release reads:...

Form 8-K - Current report

Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

Exicure, Inc. (Nasdaq: XCUR, “the Company”, “Exicure”), today announced that in connection with the change of control transaction approved by the...